Riskpilot← Back to searchSign inGet full accessEK-MED Ab
OYActiveY-tunnus 2259304-6Östernäsvägen 40Medical specialists activities · NACE 8622Est. 20099 employees
Revenue 2024
EUR 322K
+11% vs 2023
EBITDA margin
16.0%
+59% vs 2023
Equity ratio
85.3%
Financial strength
Net profit 2024
EUR 43K
+63% vs 2023
| Revenue | EUR 322K | +11% |
| EBITDA | EUR 52K | +59% |
| Net profit | EUR 43K | +63% |
| Total assets | EUR 216K | +26% |
| Equity | EUR 184K | +20% |
| Employees | 9 | — |
Legal name
EK-MED Ab
Y-tunnus number
2259304-6
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
27. maaliskuuta 2009
Share capital
EUR 2 500
Employees
9 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen yksin
Company purpose
Föremålet för bolagets verksamhets är produktion av hälso- och sjukvårdstjänster inklusive konsultationsverksamhet inom denna bransch. Bolaget kan också bedriva handel med värdepapper och därmed jämförbar verksamhet.
Address
Östernäsvägen 40
Phone
+3580405467679
Email
kristian.eriksson@aland.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 282 | 302 | 260 | 292 | 322 |
| Staff expenses | −132 | −117 | −110 | −117 | −114 |
| EBITDA | 17 | 36 | 2 | 32 | 52 |
| Depreciation & amort. | −5 | −4 | −1 | −1 | −1 |
| EBIT | 12 | 33 | 1 | 32 | 51 |
| Net financials | 3 | 3 | 2 | 1 | 3 |
| Profit before tax | 15 | 35 | 2 | 33 | 54 |
| Tax | 3 | 7 | 1 | 7 | 11 |
| Net profit | 12 | 28 | 1 | 26 | 43 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 155 | 173 | 155 | 171 | 216 |
| Equity | 130 | 148 | 138 | 153 | 184 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 25 | 25 | 17 | 18 | 32 |
| Total debt | 25 | 25 | 17 | 18 | 32 |
EBITDA margin
16.0%
This company
15.8%
Market median
+1% vs market
20202024
Equity ratio
85.3%
This company
38.2%
Market median
+123% vs market
20202024
Return on equity
23.4%
This company
18.4%
Market median
+27% vs market
20202024
Net profit margin
13.4%
This company
8.1%
Market median
+65% vs market
20202024
Asset turnover
1.49×
This company
1.12×
Market median
+33% vs market
20202024
Debt / equity
0.17×
This company
0.62×
Market median
+73% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KE Chief Executive Officer | Chief Executive Officer | 2009 |
AW Audit | Audit | 2025 |
AM Deputy Member | Deputy Member | 2021 |
| Former (4) | ||
TR Deputy auditor | Deputy auditor | 2023 – 2025 |
MK Deputy Member | Deputy Member | 2009 – 2021 |
KJ Audit | Audit | 2020 – 2025 |
LM Deputy auditor | Deputy auditor | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2009 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EK-MED Ab also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tage Ragnvald Silander | Deputy auditor | 0 companies |
| Mikael Karl Kristian Eriksson | Deputy Member | 0 companies |
| Kristian Elof Eriksson | Chief Executive Officer | 0 companies |
| Anton Wilhelm Axberg | Audit | 0 companies |
| Anna Maria Cecilia Eriksson | Deputy Member | 0 companies |
| Kjell Jörgen Jansson | Audit | 0 companies |
| Lars Magnus Lundberg | Deputy auditor | 0 companies |
| Eva Cecilia Eriksson | Board of Directors | 0 companies |